Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy

Metformin-based nanomedicines for reprogramming tumor immune microenvironment

Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy